Clinical Trials for Type 2 Diabetes
Focusing on: Sulfonylureas
Displaying 10 of 276 results.
Page 1 of 28
Completed
Conditions:Non-Insulin-Dependent Diabetes Mellitus
Interventions:metforminsulphonylureaAvandamet
Study Type:
INTERVENTIONAL
Phase:
PHASE3
Enrollment: 544
Age: 18 Years - 75 Years
Gender: ALL
Locations: GSK Investigational Site; GSK Investigational Site; +140 more
Last Updated: N/A
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
Completed
Conditions:Type II Diabetes Mellitus
Interventions:PioglitazoneMetforminSulfonylurea
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 114
Age: 18 Years - 80 Years
Gender: ALL
Locations: N/A
Last Updated: N/A
Has Results
Unknown Status
Last Known: ENROLLING_BY_INVITATION
Interventions:Sulfonylurea
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 30
Age: 2 Years - 95 Years
Gender: ALL
Locations: Department of Pediatrics and Adolescents, Haukeland University Hospital, and Department of Clinical Science, Faculty of Medicine, University of Bergen
Last Updated: N/A
Conditions:Type 2 Diabetes Mellitus
Interventions:SulphonylureaMetformn
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 726
Age: From 30 Years
Gender: ALL
Locations: N/A
Last Updated: N/A
Has Results
Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes
Completed
Conditions:Diabetes Mellitus
Interventions:discontinuation of Sulfonylureas
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 58
Age: From 19 Years
Gender: ALL
Locations: Seoul National University Hospital
Last Updated: N/A
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
Completed
Conditions:Diabetes Mellitus, Type 2
Interventions:Sulfonylurea
Study Type:
INTERVENTIONAL
Phase:
PHASE2
Enrollment: 12
Age: From 18 Years
Gender: ALL
Locations: Department of Internal Medicine, Gentofte University Hospital
Last Updated: N/A
Has Results
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Completed
Conditions:Type 2 Diabetes Mellitus
Interventions:DulaglutideInsulin glargineMetforminSulfonylureas
Study Type:
INTERVENTIONAL
Phase:
PHASE3
Enrollment: 774
Age: From 18 Years
Gender: ALL
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; +28 more
Last Updated: N/A
Has Results
Completed
Conditions:Metabolics Diabetes Nos
Interventions:Muraglitazar
Study Type:
INTERVENTIONAL
Phase:
PHASE3
Enrollment: 534
Age: 18 Years - 70 Years
Gender: ALL
Locations: Local Institution; Local Institution; +148 more
Last Updated: N/A
Conditions:Type 2 Diabetes
Interventions:Sulfonylurea
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 1069
Age: 18 Years - 75 Years
Gender: ALL
Locations: N/A
Last Updated: N/A
Has Results
Conditions:Type 2 Diabetes Mellitus
Study Type:
INTERVENTIONAL
Phase:
PHASE3
Enrollment: 361
Age: From 20 Years
Gender: ALL
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; +13 more
Last Updated: N/A
Has Results